Skip to main content

Table 2 Frequency of different AEs in the study population

From: Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

AEs Frequency of occurrence Percent of all AEs
Stomach Pain/Upset 16 22.86
GI Upset 11 15.71
Nausea 5 7.14
Reflux 5 7.14
Heartburn 4 5.71
Bloating 3 4.29
Constipation 3 4.29
Trouble with Apo-Alendronate 3 4.29
Chest Pain 2 2.86
Diarrhea 2 2.86
Loss of Appetite 2 2.86
Rectal Bleeding 2 2.86
Generally Unwell 2 2.86
Stomach Ulcer 1 1.43
Anemia 1 1.43
Rash 1 1.43
Perforated Diverticulum 1 1.43
Shortness of Breath 1 1.43
Bone Pain 1 1.43
Bowel Problems 1 1.43
Arthralgias 1 1.43
Flank Pain 1 1.43
Leg Cramping 1 1.43
Total 70 100.00
  1. AE: adverse event; GI: gastrointestinal